News & Updates

Osteoporosis screening with dual-energy X-ray absorptiometry (DXA) is recommended for all men ≥70 years of age and all women ≥65 years of age, according to 2024 guidelines of the Osteoporosis Society of Hong Kong (OSHK).

The combination of re-cellularization via electroporation therapy (ReCET) plus semaglutide appears to improve glucose control and metabolic health and eliminate the need for insulin therapy in most patients with type 2 diabetes (T2D), with the effects maintained up to 2 years, according to the follow-up data from the single-arm, dose-finding, first-in-human EMINENT trial.

The novel plant-based polyphenol-rich compound, TOTUM-63, helps keep the lid on fasting plasma glucose (FPG) and other measures of glucose dysregulation in people with prediabetes and early type 2 diabetes (T2D), according to the pivotal phase II/III REVERSE-IT study.

Several barriers on the system and organizational levels disrupt the continuous implementation of SmartMoves, an evidence-based intensive health behaviour and lifestyle treatment (IHBLT) program, for children with obesity, a study has shown.

Low-intensity obesity interventions modestly reduce BMI in children, with one in five kids in the telephonic coaching condition achieving meaningful improvement in BMI z score, reports a recent study.